Novo Nordisk Aktie
60,91
EUR
+1,96
EUR
+3,32
%
60,61
EUR
+2,28
EUR
+3,91
%
Werbung
Novo Nordisk Aktie Analyse
02.05.25 | Novo Nordisk Buy | UBS AG | |
02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.04.25 | Novo Nordisk Buy | UBS AG | |
Werbung
|
|||
22.04.25 | Novo Nordisk Buy | UBS AG | |
22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
08.04.25 | Novo Nordisk Buy | UBS AG | |
07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | Novo Nordisk Buy | UBS AG | |
03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
31.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.03.25 | Novo Nordisk Buy | UBS AG | |
17.03.25 | Novo Nordisk Buy | UBS AG | |
14.03.25 | Novo Nordisk Buy | UBS AG | |
12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.03.25 | Novo Nordisk Buy | UBS AG | |
04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
03.03.25 | Novo Nordisk Buy | UBS AG | |
26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
24.02.25 | Novo Nordisk Buy | UBS AG | |
20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.02.25 | Novo Nordisk Buy | UBS AG | |
17.02.25 | Novo Nordisk Buy | Deutsche Bank AG |
Werbung
Werbung